Kenvue General Counsel granted 122,286 RSUs

Kenvue Inc. reported that its General Counsel, Matthew Orlando, received a grant of 122,286 Restricted Stock Units (RSUs) on March 2, 2026.

Accepted by SEC EDGAR 03/04/2026 - 05:15 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Kenvue Inc. reported that its General Counsel, Matthew Orlando, received a grant of 122,286 Restricted Stock Units (RSUs) on March 2, 2026. These RSUs were acquired at a price of $0.00 per unit as a compensation award and now represent his total reported RSU holdings.

The units correspond on a 1-for-1 basis with Kenvue common stock. The award is scheduled to vest in three equal installments on March 2, 2027, March 2, 2028, and March 2, 2029, provided he continues in service through each vesting date.

Insider Trade Summary

Grant/Award: 122,286 shares

Grant/Award 1 txn

Insider Orlando Matthew

Role General Counsel

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	122,286	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 122,286 contracts (Direct)

Holdings Before and After: Restricted Stock Units, 0 to 122,286 contracts (Direct)

Footnotes (2)

1. F1. These units correspond 1 for 1 with the Company's common stock.
2. F2. This award vests in three equal installments on 03/02/2027, 03/02/2028, and 03/02/2029, subject to the reporting person's continued service through such vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Kenvue (KVUE) report for Matthew Orlando?

Kenvue reported that General Counsel Matthew Orlando received a grant of 122,286 Restricted Stock Units. The award was recorded at $0.00 per unit as part of his compensation and increases his reported RSU holdings to the same amount.

How many Kenvue (KVUE) RSUs were granted to the General Counsel?

Matthew Orlando was granted 122,286 Restricted Stock Units in Kenvue. Each unit corresponds one-for-one with a share of Kenvue common stock, meaning the award can translate into an equal number of shares if and when it vests.

When do Matthew Orlando’s Kenvue (KVUE) RSUs vest?

The RSU award vests in three equal installments on March 2, 2027, March 2, 2028, and March 2, 2029. Vesting is contingent on Matthew Orlando’s continued service with Kenvue through each of those vesting dates.

What is the relationship between Kenvue (KVUE) RSUs and common stock in this Form 4?

The filing states that the granted Restricted Stock Units correspond one-for-one with Kenvue’s common stock. This means each RSU represents the right to receive one share of common stock upon vesting and settlement, subject to the award’s terms.

Did the Kenvue (KVUE) General Counsel buy or sell shares in this Form 4?

The transaction is classified as an acquisition through a grant or award, not an open-market buy or sell. Matthew Orlando received 122,286 RSUs at $0.00 per unit as part of his compensation, increasing his reported derivative holdings.

What conditions apply to the Kenvue (KVUE) RSU award for Matthew Orlando?

The award’s vesting is subject to Matthew Orlando’s continued service through each vesting date. If he remains in his role through March 2 in 2027, 2028, and 2029, the RSUs are scheduled to vest in three equal installments on those dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Orlando Matthew

(Last) (First) (Middle)

1 KENVUE WAY

(Street)

SUMMIT NJ 07901

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Kenvue Inc. [ KVUE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/02/2026		A		122,286		(2)	(2)	Common Stock	122,286	$0	122,286	D

Explanation of Responses:

1. These units correspond 1 for 1 with the Company's common stock.

2. This award vests in three equal installments on 03/02/2027, 03/02/2028, and 03/02/2029, subject to the reporting person's continued service through such vesting date.

Remarks:

	/s/ Alla Berenshteyn, as attorney-in-fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.